Results 201 to 210 of about 1,766,628 (360)

ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity.

open access: yesJournal of Proteomics, 2015
Tao Xu   +16 more
semanticscholar   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet disease. [PDF]

open access: yesRMD Open
Akbaba TH   +10 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Clinical Sensitivity and Specificity of the PROSTest in an American Cohort. [PDF]

open access: yesProstate
Rahbar K   +5 more
europepmc   +1 more source

Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography.

open access: yesSleep, 2013
M. Marino   +9 more
semanticscholar   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

FoundationOne CDx and FoundationOne Heme Detect Epstein-Barr Virus with High Sensitivity and Specificity. [PDF]

open access: yesJ Mol Diagn
Honecker J   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy